Company Filing History:
1 out of 230 
1 out of 263 Years Active: 2021
Title: The Innovative Contributions of María Lourdes Rueda Benede
Introduction
María Lourdes Rueda Benede is a notable inventor based in Collegeville, PA, who has made significant contributions to the field of pharmaceuticals. His work primarily focuses on the development of compounds that can inhibit DNMT1, a critical enzyme involved in various diseases, including cancer.
Latest Patents
Rueda Benede holds a patent for "Substituted pyridines as inhibitors of DNMT1." This invention is directed to substituted pyridine derivatives, specifically compounds that are selective inhibitors of DNMT1. These compounds can be useful in treating cancer, pre-cancerous syndromes, beta hemoglobinopathy disorders, sickle cell disease, sickle cell anemia, and beta thalassemia. The invention also encompasses pharmaceutical compositions that include these compounds and methods for inhibiting DNMT1 activity.
Career Highlights
Throughout his career, Rueda Benede has worked with prominent organizations, including GlaxoSmithKline Intellectual Property Development Limited and Cancer Research Technology Limited. His experience in these companies has allowed him to contribute to significant advancements in medical research and drug development.
Collaborations
Rueda Benede has collaborated with notable colleagues, including Nicholas D. Adams and Andrew B. Benowitz. These partnerships have further enhanced his research and development efforts in the pharmaceutical industry.
Conclusion
María Lourdes Rueda Benede's innovative work in developing DNMT1 inhibitors showcases his commitment to advancing medical science. His contributions have the potential to impact the treatment of various serious health conditions significantly.